9 Intriguingly, some of the LABA/LAMA FDCs showed a numerical trend in protecting against cardiovascular SAEs, whereas other combinations showed a signal in increasing the risk of cardiovascular SAEs. 9 The frequencies of SAEs and deaths in RCTs of LABA/LAMA FDCs are low.
← all excerpts
LABA/LAMA fixed-dose combinations in patients with COPD: a systematic review.
1
—
—